Olivier T. Giger

Hill's Road
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Phosphodiesterase 3 A expression in gastrointestinal stromal tumors.

Phosphodiesterase 3 A expression in gastrointestinal stromal tumors.

Journal: Virchows Archiv : an international journal of pathology

Published: May 02, 2025

In vivo gastrin releasing peptide receptor expression in SDH deficient wild-type gastrointestinal stromal tumours (GIST): potential for theranostic applications.

In vivo gastrin releasing peptide receptor expression in SDH deficient wild-type gastrointestinal stromal tumours (GIST): potential for theranostic applications.

Journal: EJNMMI research

Published: April 25, 2025

Publisher Correction: Novel immunotherapeutics against LGR5 to target multiple cancer types.

Publisher Correction: Novel immunotherapeutics against LGR5 to target multiple cancer types.

Journal: EMBO molecular medicine

Published: September 25, 2024

Author Correction: Disentangling oncogenic amplicons in esophageal adenocarcinoma.

Author Correction: Disentangling oncogenic amplicons in esophageal adenocarcinoma.

Journal: Nature communications

Published: May 28, 2024

Novel immunotherapeutics against LGR5 to target multiple cancer types.

Novel immunotherapeutics against LGR5 to target multiple cancer types.

Journal: EMBO molecular medicine

Published: February 16, 2024

Disentangling oncogenic amplicons in esophageal adenocarcinoma.

Disentangling oncogenic amplicons in esophageal adenocarcinoma.

Journal: Nature communications

Published: August 15, 2023

Preferential MGMT hypermethylation in SDH-deficient wild-type GIST.

Preferential MGMT hypermethylation in SDH-deficient wild-type GIST.

Journal: Journal of clinical pathology

Published: June 28, 2022

ELEVATE - evaluating Temozolomide and Nivolumab in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma with MGMT methylation: study protocol for a single arm phase II trial.

ELEVATE - evaluating Temozolomide and Nivolumab in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma with MGMT methylation: study protocol for a single arm phase II trial.

Journal: BMC cancer

Published: February 15, 2022

Investigating the clinical, pathological and molecular profile of oncocytic adrenocortical neoplasms: a case series and literature review.

Investigating the clinical, pathological and molecular profile of oncocytic adrenocortical neoplasms: a case series and literature review.

Journal: Endocrine oncology (Bristol, England)

Published: August 09, 2021

Breast cancer in multiple endocrine neoplasia type 1 (MEN1).

Breast cancer in multiple endocrine neoplasia type 1 (MEN1).

Journal: Endocrinology, diabetes & metabolism case reports

Published: March 22, 2021

Familial wild-type gastrointestinal stromal tumour in association with germline truncating variants in both SDHA and PALB2.

Familial wild-type gastrointestinal stromal tumour in association with germline truncating variants in both SDHA and PALB2.

Journal: European journal of human genetics : EJHG

Published: November 06, 2020

The role of [68 Ga]Ga-DOTATATE PET/CT in wild-type KIT/PDGFRA gastrointestinal stromal tumours (GIST).

The role of [68 Ga]Ga-DOTATATE PET/CT in wild-type KIT/PDGFRA gastrointestinal stromal tumours (GIST).

Journal: EJNMMI research

Published: October 27, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026